Analytical Data
-
基因名
ERK2
- Application
-
别名
MAPK1; P38; P40; ERK2; ERT1; MAPK2; P42MAPK; P42-MAPK; PRKM1; PRKM2; P41; P41mapk; P41-mapk; Mitogen-Activated Protein Kinase 1; Mitogen-activated protein kinase 2
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P28482
-
表达区间
Tyr25~Ser360
-
分子量
43kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Extracellular signal-regulated kinase 2 (ERK2), part of the mitogen-activated protein kinase (MAPK) signaling pathway, plays a pivotal role in regulating various cellular processes, including proliferation, differentiation, and survival. Its activation is triggered by upstream signaling molecules in response to growth factors and stress, leading to the phosphorylation of numerous downstream substrates. Research on ERK2 recombinantly expressed protein has gained significant attention due to its involvement in key cellular functions and its implications in various diseases, including cancer, where aberrant ERK signaling is often observed. Understanding ERK2’s structure, function, and regulatory mechanisms is critical for elucidating its role in pathophysiology and developing targeted therapeutic strategies. The recombinant production of ERK2 allows for detailed biochemical and biophysical studies, facilitating the exploration of its interactions with other proteins and small molecules. Moreover, generating specific mutants of ERK2 can aid in dissecting the intricacies of its signaling pathway. This research not only contributes to basic scientific knowledge but also holds promise for identifying novel drug targets and biomarkers in diseases associated with ERK2 dysregulation, making it a focal point in biomedical research.












